TScan Therapeutics (NASDAQ:TCRX) Price Target Cut to $10.00 by Analysts at HC Wainwright
TScan Therapeutics (NASDAQ:TCRX – Free Report) had its target price lowered by HC Wainwright from $15.00 to $10.00 in a research note published on Wednesday morning, Marketbeat.com reports. The brokerage currently has a buy rating on the stock. HC Wainwright also issued estimates for TScan Therapeutics’ FY2029 earnings at $0.32 EPS. Several other equities research […]
TScan Therapeutics (NASDAQ:TCRX – Free Report) had its target price lowered by HC Wainwright from $15.00 to $10.00 in a research note published on Wednesday morning, Marketbeat.com reports. The brokerage currently has a buy rating on the stock. HC Wainwright also issued estimates for TScan Therapeutics’ FY2029 earnings at $0.32 EPS. Several other equities research […]
